Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $373.65 | 10 | 95.6% |
| Education | $17.30 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $102.26 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $101.88 | 5 | $0 (2024) |
| AbbVie, Inc. | $96.18 | 1 | $0 (2018) |
| CooperSurgical, Inc. | $40.36 | 1 | $0 (2019) |
| Myovant Sciences Inc. | $17.80 | 1 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $17.30 | 1 | $0 (2018) |
| Mylan Pharmaceuticals Inc. | $15.17 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.70 | 2 | Merck Sharp & Dohme LLC ($44.70) |
| 2022 | $17.80 | 1 | Myovant Sciences Inc. ($17.80) |
| 2019 | $188.34 | 4 | Genentech USA, Inc. ($102.26) |
| 2018 | $140.11 | 4 | AbbVie, Inc. ($96.18) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: ONCOLOGY | ||||||
| 08/04/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: HORMONE THERAPY | ||||||
| 10/10/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $17.78 | General |
| 03/17/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2019 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $102.26 | General |
| Category: BioOncology | ||||||
| 02/01/2019 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $40.36 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 12/19/2018 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $96.18 | General |
| Category: Endocrinology | ||||||
| 09/19/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $17.30 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 03/28/2018 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Women's Healthcare | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 18 | $3,481 | $901.46 |
| 2021 | 1 | 11 | 19 | $5,624 | $1,795 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 18 | $3,481 | $901.46 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 19 | $5,624 | $1,795 | 31.9% |
About Dr. Harriet Smith, MD
Dr. Harriet Smith, MD is a Gynecologic Oncology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437166485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harriet Smith, MD has received a total of $390.95 in payments from pharmaceutical and medical device companies, with $44.70 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($373.65).
As a Medicare-enrolled provider, Smith has provided services to 24 Medicare beneficiaries, totaling 37 services with total Medicare billing of $2,697. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Bronx, NY
- Active Since 08/02/2006
- Last Updated 10/21/2011
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1437166485
Products in Payments
- Avastin (Biological) $102.26
- Lupron (Drug) $96.18
- LYNPARZA (Biological) $56.16
- Endosee (Device) $40.36
- KEYTRUDA (Biological) $27.94
- MYFEMBREE (Drug) $17.80
- INTRAROSA (Drug) $17.30
- Xulane (Drug) $15.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Bronx
Ioannis Alagkiozidis, Md, MD
Gynecologic Oncology — Payments: $3,869
Dr. Ken Lin, Md, Phd, MD, PHD
Gynecologic Oncology — Payments: $2,823
Dr. Matthew Cowan, D.o, D.O
Gynecologic Oncology — Payments: $2,279
Gary Goldberg, Md, MD
Gynecologic Oncology — Payments: $1,259
Dennis Kuo, Md, MD
Gynecologic Oncology — Payments: $561.25
David Smotkin, M.d, M.D
Gynecologic Oncology